Patrick L. McGeer

53.3k total citations · 10 hit papers
492 papers, 42.7k citations indexed

About

Patrick L. McGeer is a scholar working on Physiology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Patrick L. McGeer has authored 492 papers receiving a total of 42.7k indexed citations (citations by other indexed papers that have themselves been cited), including 201 papers in Physiology, 160 papers in Neurology and 154 papers in Cellular and Molecular Neuroscience. Recurrent topics in Patrick L. McGeer's work include Alzheimer's disease research and treatments (170 papers), Neuroinflammation and Neurodegeneration Mechanisms (124 papers) and Neuroscience and Neuropharmacology Research (89 papers). Patrick L. McGeer is often cited by papers focused on Alzheimer's disease research and treatments (170 papers), Neuroinflammation and Neurodegeneration Mechanisms (124 papers) and Neuroscience and Neuropharmacology Research (89 papers). Patrick L. McGeer collaborates with scholars based in Canada, Japan and United States. Patrick L. McGeer's co-authors include Edith G. McGeer, Haruhiko Akiyama, Shigeru Itagaki, Claudia Schwab, Andis Klegeris, Koji Yasojima, Douglas G. Walker, Barry E. Boyes, Hiroshi Kimura and Michael Schulzer and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Patrick L. McGeer

489 papers receiving 41.3k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

1988 2.4k citations Patrick L. McGeer, Shigeru Itagaki et al. Neurology profile →
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease

1996 1.1k citations Patrick L. McGeer, Edith G. McGeer et al. Neurology profile →
Kainic acid as a tool in neurobiology

1978 1.1k citations Edith G. McGeer, Patrick L. McGeer et al. profile →
Clinical trial of indomethacin in Alzheimer's disease

1993 804 citations Patrick L. McGeer et al. Neurology profile →
The central cholinergic system studied by choline acetyltransferase immunohistochemistry in the cat

1981 731 citations Hiroshi Kimura, Patrick L. McGeer et al. profile →
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR

1987 701 citations Patrick L. McGeer, Shigeru Itagaki et al. Neuroscience Letters profile →
Complement activation by beta-amyloid in Alzheimer disease.

1992 667 citations Patrick L. McGeer et al. profile →
Glial reactions in Parkinson's disease

2007 567 citations Patrick L. McGeer, Edith G. McGeer profile →
Microglia in degenerative neurological disease

1993 512 citations Patrick L. McGeer, Edith G. McGeer et al. profile →
Aging and Extrapyramidal Function

1977 473 citations Patrick L. McGeer, Edith G. McGeer et al. profile →

Peers

Countries citing papers authored by Patrick L. McGeer

Since Specialization

Citations

This map shows the geographic impact of Patrick L. McGeer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick L. McGeer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick L. McGeer more than expected).

Fields of papers citing papers by Patrick L. McGeer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick L. McGeer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick L. McGeer. The network helps show where Patrick L. McGeer may publish in the future.

Co-authorship network of co-authors of Patrick L. McGeer

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick L. McGeer. A scholar is included among the top collaborators of Patrick L. McGeer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick L. McGeer. Patrick L. McGeer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biological Imaging with Medium‐Sensitive Bichromatic Flexible Fluorescent Dyes 2017 ·Angewandte Chemie ·Yang Cao, Xiaozhu Wang, Xiaolei Shi, Susanne M. Clee, Patrick L. McGeer, Michael O. Wolf, Chris Orvig	8
2	Biological Imaging with Medium‐Sensitive Bichromatic Flexible Fluorescent Dyes 2017 ·Angewandte Chemie International Edition ·Yang Cao, Xiaozhu Wang, Xiaolei Shi, Susanne M. Clee, Patrick L. McGeer, Michael O. Wolf, Chris Orvig	31
3	Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs 2017 ·Journal of Alzheimer s Disease ·Patrick L. McGeer, Jian Guo, Moon‐Hee Lee, (unknown), Edith G. McGeer	58
4	Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly 2017 ·Journal of Alzheimer s Disease ·Ersilia De Lorenzi, Marcella Chiari, Raffaella Colombo, Marina Cretich, Laura Solá, Renzo Vanna, Paola Gagni, (unknown), Carlo Morasso, Jennifer S Lin, Moon‐Hee Lee, Patrick L. McGeer, Annelise E. Barron	41
5	Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages 2012 ·Neurobiology of Aging ·Moon‐Hee Lee, Jian‐Ping Guo, Edith G. McGeer, Patrick L. McGeer	10
6	Amyloid-β42 Interacts Mainly with Insoluble Prion Protein in the Alzheimer Brain 2011 ·Journal of Biological Chemistry ·Wen‐Quan Zou, Xiangzhu Xiao, Jue Yuan, Gianfranco Puoti, Hisashi Fujioka, Xinglong Wang, (unknown), Xiaochen Zhou, Roger S. Zou, Shihao Li, Xiongwei Zhu, Patrick L. McGeer, J.E. McGeehan, G.G. Kneale, Diego E. Rincón-Limas, Pedro Fernández-Fúnez, Hyoung‐gon Lee, Mark A. Smith, Robert B. Petersen, (unknown)	67
7	Identification of ciliary neurotrophic factor receptor α as a mediator of neurotoxicity induced by α‐synuclein 2010 ·PROTEOMICS ·Jun Liu, Min Shi, Zhen Hong, (unknown), (unknown), Joshua M. Bradner, Thomas J. Quinn, Richard P. Beyer, Patrick L. McGeer, Shengdi Chen, Jing Zhang	10
8	Immunotherapy for neurological diseases 2008 ·Clinical Immunology ·Pablo Villoslada, Beatriz Moreno, Ignacio Melero, José L. Pablos, Gianvito Martino, Antonio Uccelli, Xavier Montalbán, Jesús Ávila, Serge Rivest, Laia Acarín, Stanley H. Appel, Samia J. Khoury, Patrick L. McGeer, Isidró Ferrer, Mario Delgado, José Á. Obeso, Michal Schwartz	43
9	Neuroscientific Basis of Dementia 2001 ·Birkhäuser Basel eBooks ·Chikako Tanaka, Patrick L. McGeer, Yasuo Ihara	6
10	Aβ42-Carboxy-Terminal-like Immunoreactivity Is Associated with Intracellular Neurofibrillary Tangles and Pick Bodies 2000 ·Experimental Neurology ·C. William Schwab, Patrick L. McGeer	15
11	Casein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases 2000 ·Neurobiology of Aging ·Claudia Schwab, Anthony J. DeMaggio, Nupur Ghoshal, Lester I. Binder, Jeff Kuret, Patrick L. McGeer	130
12	Toxicity of human THP-1 monocytic cells towards neuron-like cells is reduced by non-steroidal anti-inflammatory drugs (NSAIDs) 1999 ·Neuropharmacology ·Andis Klegeris, D G Walker, Patrick L. McGeer	71
13	Complement regulators C1 inhibitor and CD59 do not significantly inhibit complement activation in Alzheimer disease 1999 ·Brain Research ·Koji Yasojima, Edith G. McGeer, Patrick L. McGeer	46
14	Vitronectin expression in Purkinje cells in the human cerebellum 1998 ·Neuroscience Letters ·D G Walker, Patrick L. McGeer	14
15	Histological and biochemical pathology in a family with autosomal dominant Parkinsonism and dementia 1993 ·Neurology Psychiatry and Brain Research ·Tōru Yamada, Edith G. McGeer, Robert L. Schelper, Zbigniew K. Wszołek, Patrick L. McGeer, Ronald F. Pfeiffer, Robert L. Rodnitzky	37
16	Accumulation of amyloid precursor protein in damaged neuronal processes and microglia following intracerebral administration of aluminum salts 1992 ·Brain Research ·Kazuo Shigematsu, Patrick L. McGeer	48
17	The efferent projections of the rat lateral habenular nucleus revealed by the PHA-L anterograde tracing method 1988 ·Brain Research ·Masasuke Araki, Patrick L. McGeer, Hiroshi Kimura	127
18	Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains breakdown → 1988 ·Neurology ·Patrick L. McGeer, Shigeru Itagaki, Barry E. Boyes, Edith G. McGeer	2380
19	Transplantation of cultured human adrenal chromaffin cells into 6‐hydroxydopamine‐lesioned rat brain 1987 ·Synapse ·H. Kamo, Seung Up Kim, Patrick L. McGeer, Hisao Tago, (unknown)	17
20	A distinctive distribution of reactive astroglia in the precentral cortex in amyotrophic lateral sclerosis 1987 ·Acta Neuropathologica ·H. Kamo, H. Haebara, Ichiro Akiguchi, M Kameyama, Hiroshi Kimura, Patrick L. McGeer	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact